692 related articles for article (PubMed ID: 26005850)
61. RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier.
Deane R; Wu Z; Zlokovic BV
Stroke; 2004 Nov; 35(11 Suppl 1):2628-31. PubMed ID: 15459432
[TBL] [Abstract][Full Text] [Related]
62. High-Density Lipoprotein Mimetic Peptide 4F Efficiently Crosses the Blood-Brain Barrier and Modulates Amyloid-
Swaminathan SK; Zhou AL; Ahlschwede KM; Curran GL; Lowe VJ; Li L; Kandimalla KK
J Pharmacol Exp Ther; 2020 Nov; 375(2):308-316. PubMed ID: 32778535
[TBL] [Abstract][Full Text] [Related]
63. Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease.
Hartz AM; Miller DS; Bauer B
Mol Pharmacol; 2010 May; 77(5):715-23. PubMed ID: 20101004
[TBL] [Abstract][Full Text] [Related]
64. Astaxanthin enhances autophagy, amyloid beta clearance and exerts anti-inflammatory effects in in vitro models of Alzheimer's disease-related blood brain barrier dysfunction and inflammation.
Babalola JA; Lang M; George M; Stracke A; Tam-Amersdorfer C; Itxaso I; Lucija D; Tadic J; Schilcher I; Loeffler T; Flunkert S; Prokesch M; Leitinger G; Lass A; Hutter-Paier B; Panzenboeck U; Hoefler G
Brain Res; 2023 Nov; 1819():148518. PubMed ID: 37579986
[TBL] [Abstract][Full Text] [Related]
65. Blood-brain barrier transcytosis genes, risk of dementia and stroke: a prospective cohort study of 74,754 individuals.
Juul Rasmussen I; Tybjærg-Hansen A; Rasmussen KL; Nordestgaard BG; Frikke-Schmidt R
Eur J Epidemiol; 2019 Jun; 34(6):579-590. PubMed ID: 30830563
[TBL] [Abstract][Full Text] [Related]
66. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.
Deane R; Sagare A; Hamm K; Parisi M; Lane S; Finn MB; Holtzman DM; Zlokovic BV
J Clin Invest; 2008 Dec; 118(12):4002-13. PubMed ID: 19033669
[TBL] [Abstract][Full Text] [Related]
67. PCSK9 acts as a key regulator of Aβ clearance across the blood-brain barrier.
Mazura AD; Ohler A; Storck SE; Kurtyka M; Scharfenberg F; Weggen S; Becker-Pauly C; Pietrzik CU
Cell Mol Life Sci; 2022 Mar; 79(4):212. PubMed ID: 35344086
[TBL] [Abstract][Full Text] [Related]
68. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
Kurz C; Walker L; Rauchmann BS; Perneczky R
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
[TBL] [Abstract][Full Text] [Related]
69. Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1.
Ramanathan A; Nelson AR; Sagare AP; Zlokovic BV
Front Aging Neurosci; 2015; 7():136. PubMed ID: 26236233
[TBL] [Abstract][Full Text] [Related]
70. Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives.
Cheng Y; Tian DY; Wang YJ
Transl Neurodegener; 2020 May; 9(1):16. PubMed ID: 32381118
[TBL] [Abstract][Full Text] [Related]
71. Copper Exposure Perturbs Brain Inflammatory Responses and Impairs Clearance of Amyloid-Beta.
Kitazawa M; Hsu HW; Medeiros R
Toxicol Sci; 2016 Jul; 152(1):194-204. PubMed ID: 27122238
[TBL] [Abstract][Full Text] [Related]
72. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
73. Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model.
Qosa H; Batarseh YS; Mohyeldin MM; El Sayed KA; Keller JN; Kaddoumi A
ACS Chem Neurosci; 2015 Nov; 6(11):1849-59. PubMed ID: 26348065
[TBL] [Abstract][Full Text] [Related]
74. Clearance of amyloid-β peptide across the choroid plexus in Alzheimer's disease.
Alvira-Botero X; Carro EM
Curr Aging Sci; 2010 Dec; 3(3):219-29. PubMed ID: 20735345
[TBL] [Abstract][Full Text] [Related]
75. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
Deane R; Zlokovic BV
Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
[TBL] [Abstract][Full Text] [Related]
76. Distinct Uptake Kinetics of Alzheimer Disease Amyloid-
Sharda N; Ahlschwede KM; Curran GL; Lowe VJ; Kandimalla KK
J Pharmacol Exp Ther; 2021 Mar; 376(3):482-490. PubMed ID: 33303699
[TBL] [Abstract][Full Text] [Related]
77. Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.
Ando K; Tomimura K; Sazdovitch V; Suain V; Yilmaz Z; Authelet M; Ndjim M; Vergara C; Belkouch M; Potier MC; Duyckaerts C; Brion JP
Neurobiol Dis; 2016 Oct; 94():32-43. PubMed ID: 27260836
[TBL] [Abstract][Full Text] [Related]
78. Transplantation of in vitro cultured endothelial progenitor cells repairs the blood-brain barrier and improves cognitive function of APP/PS1 transgenic AD mice.
Zhang S; Zhi Y; Li F; Huang S; Gao H; Han Z; Ge X; Li D; Chen F; Kong X; Lei P
J Neurol Sci; 2018 Apr; 387():6-15. PubMed ID: 29571873
[TBL] [Abstract][Full Text] [Related]
79. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.
Bell RD; Sagare AP; Friedman AE; Bedi GS; Holtzman DM; Deane R; Zlokovic BV
J Cereb Blood Flow Metab; 2007 May; 27(5):909-18. PubMed ID: 17077814
[TBL] [Abstract][Full Text] [Related]
80. Characterization of Hit Compounds Identified from High-throughput Screening for their Effect on Blood-brain Barrier Integrity and Amyloid-β Clearance: In Vitro and In Vivo Studies.
Elfakhri KH; Duong QV; Langley C; Depaula A; Mousa YM; Lebeouf T; Cain C; Kaddoumi A
Neuroscience; 2018 May; 379():269-280. PubMed ID: 29596966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
